Beovu (brolucizumab)

pCPA File Number: 22193
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetic Macular Edema
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0747-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: